[1]
Yonal, O. et al. 2014. No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects. Turkish Journal of Gastroenterology. 25, 6 (Jan. 2014), 639–643. DOI:https://doi.org/10.5152/tjg.2014.6568.